Preclinical trials of B7-H4 in immunotherapy for ovarian cancer (PDX, patient-derived xenograft; CDX: cell line-derived xenograft; ADCC, antibody-dependent cellular cytotoxicity; ADCP, Antibody dependent cell-mediated phagocytosis). This evidence concerns the gene VTCN1 and ovarian cancer.